Jul 23, 2026 07:30AM
Jun 11, 2026 07:00AM
Jun 11, 2026 07:00AM
May 7, 2026 07:14AM
May 7, 2026 07:00AM
Apr 23, 2026 07:30AM
Mar 2, 2026 07:03AM Xeris Pharmaceuticals Inc. (XERS) Tops Q4 EPS by 4c, provides guidance
Mar 2, 2026 07:00AM
Feb 26, 2026 06:40PM
Feb 26, 2026 05:55PM
Feb 17, 2026 07:30AM
Jan 8, 2026 07:00AM
Dec 1, 2025 07:01AM
Dec 1, 2025 07:00AM Xeris Announces Notice of Allowance from U.S. Patent and Trademark Office for XP-8121 Patent Application
Nov 6, 2025 07:01AM
Nov 6, 2025 07:00AM
Oct 23, 2025 07:30AM
Aug 7, 2025 07:03AM
Aug 7, 2025 07:00AM
Jul 31, 2025 07:30AM
May 8, 2025 07:03AM Xeris Pharmaceuticals Inc. (XERS) Misses Q1 EPS by 1c, provides guidance
May 8, 2025 07:00AM
May 1, 2025 07:00AM
Mar 6, 2025 07:04AM
Mar 6, 2025 07:00AM
Feb 27, 2025 07:00AM
Jan 10, 2025 07:05AM
Jan 10, 2025 07:00AM Xeris Expects to Exceed Full-Year 2024 Financial Guidance
Nov 8, 2024 07:03AM
Nov 8, 2024 07:00AM
Oct 31, 2024 08:00AM
Aug 8, 2024 07:11AM
Aug 8, 2024 07:00AM
Jul 25, 2024 07:00AM
Jul 8, 2024 07:00AM Xeris Biopharma Announces CEO Succession Plan
May 9, 2024 07:04AM
May 9, 2024 07:00AM
May 2, 2024 07:00AM
Mar 6, 2024 07:04AM
Mar 6, 2024 07:02AM
Feb 28, 2024 07:00AM
Jan 4, 2024 07:04AM Xeris Pharmaceuticals (XERS) Updates 2023 Outlook
Jan 4, 2024 07:00AM
Nov 9, 2023 07:05AM
Nov 9, 2023 07:00AM
Oct 16, 2023 07:01AM
Oct 16, 2023 07:00AM
Aug 8, 2023 07:08AM
Aug 8, 2023 07:00AM Xeris Biopharma Reports Second Quarter 2023 Financial Results
Aug 1, 2023 07:00AM

1,208,459 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All